Spray-on_skin

Spray-on skin

Spray-on skin

Skin culturing treatment for burn or other skin damage victims

Spray-on skin is a skin culturing treatment for burn, or other skin damage victims. It involves taking small samples of the patient's skin and spraying them on the wound.[1]

Preparation of spray-on skin using a ReCell device

History

The treatment was developed by Marie Stoner and plastic surgeon Fiona Wood. Their technique worked quicker than previous skin culturing techniques.[2] Wood established the company Avita Medical in 1993 to commercialise the procedure.[3]

After the 2002 Bali bombings, Wood used the experimental technology on victims before it had been subjected to proper clinical trials, garnering criticism from other burn specialists since at the time there was little evidence of its efficacy, and Wood had an apparent conflict of interest since she founded the company that sold the technology.[4]

A 2006 clinical trial in US attracted only small numbers of participants and was suspended by Avita.[5] Clinical trials commenced again in 2010 with the assistance of a grant from the US Army.[5][1] Participant rates for the new trial were again lower than expected.[1]

The technology is currently approved for use in Australia, Europe, Britain and North America.[5][6]

References

  1. [1]
    "Spray-on skin company Avita Medical faces investor revolt". smh.com.au. 18 November 2013. Retrieved 2014-03-30.
  2. [2]
    "Australia of the Year – 2005 Award". australianoftheyear.gov.au. 2005. Archived from the original on 10 October 2006.
  3. [3]
    Spray on Skin
  4. [4]
    Carol Nader (January 29, 2005). "Jury still out over 'spray-on skin'". The Age. Retrieved 2007-12-19.
  5. [5]
    "FDA approves Avita Medical ReCell® Spray-On Skin clinical trial in USA". 8 December 2009. Retrieved 2014-03-30.
  6. [6]
    "Spray-on skin speeds up healing burns". abc.net.au. 23 November 2009. Retrieved 2014-03-30.
Share this article:

This article uses material from the Wikipedia article Spray-on_skin, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.